Weave Bio

About Weave Bio

Weave is a company focused on transforming regulatory workflows through AI-powered solutions. Their mission is to streamline the creation and management of complex regulatory dossiers, enabling teams to deliver documents efficiently and accurately with innovative technology.

Products & Services

Weave Platform:An AI-driven platform for regulatory automation that generates documents, integrates data, and facilitates real-time team collaboration. It supports customizable templates, rapid content updates, and traceability of data for biotech, pharma, and CROs.

Specialties

Regulatory Automation AI for Document Generation Data Integration Real-time Collaboration Tools

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 20000000 MR: - FA: 20 million FAN: 20000000	D: 2025-10-16 FD: 2025-10-16	6 investors
2	RT: Seed T: - FT: Seed	A: 10000000 MR: - FA: $10M FAN: 10000000	D: 2024-05-30 FD: 2024-05-30	2 investors

Series A Latest

2025-10-16

$20.0M

6 investors (Pro only)

Seed 2024-05-30

$10.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Weave Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised